2024年IBD研究中的挑战:临床前人类IBD机制
Matthew A Ciorba1, Liza Konnikova2, Simon A Hirota3
1Inflammatory Bowel Diseases Center, Division of Gastroenterology, Washington University in St. Louis, Saint Louis, MO, USA.
Inflammatory bowel diseases
|May 23, 2024
概括
这项研究确定了临床前炎性肠病 (IBD) 机制中的关键缺口,为IBD拦截和缓解提供了可行的策略. 解决这些临床前研究需求是推动IBD患者护理的关键.
科学领域:
- 胃肠道学和免疫学
- 临床前研究 临床前研究
- 炎症性肠病 (IBD) 的机制
背景情况:
- 炎症性肠病 (IBD) 研究面临重大挑战,特别是在了解临床前机制方面.
- 涉及科学家,临床医生,患者和资助者的多学科方法对于优先考虑研究至关重要.
- "2024年IBD研究中的挑战"文件强调了临床前机制作为一个关键重点领域.
研究的目的:
- 提供关于临床前IBD机制当前研究缺陷的全面概述.
- 提出可行的方法来解决这些差距,重点关注IBD拦截,缓解和恢复.
- 通过识别未满足的医疗需求,指导以患者为中心的研究优先级.
主要方法:
- 通过多学科投入,识别研究缺口.
- 将缺口分类为关键领域:遗传学,微生物组,细胞状态,屏障功能,并发症和肠外表现.
- 为基础和转化科学家提供具体机会的发展.
主要成果:
- 在遗传学,风险等位基因,表观遗传学,微生物组,细胞状态和相互作用,屏障功能,纤维化/狭窄化和肠外表现方面发现了主要的研究缺口.
- 阐明关键的途径和机制,以针对未满足的IBD需求.
- 为基础研究和翻译研究提出可行的战略和优先行动.
结论:
- 解决已识别的临床前研究缺口对于推进IBD理解和治疗至关重要.
- 调查这些差距将有助于开发新的IBD拦截,缓解和恢复策略.
- 这些发现为未来以患者为中心的IBD机制研究提供了路线图.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
165
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
165
01:30Inflammatory Bowel Disease II: Crohn's Disease
217
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
217
01:29Inflammatory Bowel Disease IV: Pharmacological Management
126
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
126
01:17Chronic Bowel Disorders: Introduction
442
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
442
01:17Irritable Bowel Syndrome I: Introduction
268
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
268